LBI-HTA - Publications - Search - Person: Püntmann, I.
Number of items: 1.

Nachtnebel, A. and Püntmann, I. (2011): Abiraterone acetate (Zytiga™) as 2nd-line therapy for the treatment of metastatic castration resistant prostate cancer after docetaxel therapy. DSD: Horizon Scanning in Oncology 20.

This list was generated on Sun May 28 02:01:34 2017 CEST.